Evaluation of the clinical utility of the nuclear-localized AR-V7 biomarker in CTCs in the context of physician intuition measured through physician therapy choice propensity and patient risk.
Evaluation of the clinical utility of the nuclear-localized AR-V7 biomarker in CTCs in the context of physician intuition measured through physician therapy choice propensity and patient risk.